Rajesh Ramakrishnan
University of Arizona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajesh Ramakrishnan.
Virology Journal | 2007
Vasudha Sundaravaradan; Suman R. Das; Rajesh Ramakrishnan; Shobha Sehgal; Sarla Gopalan; Nafees Ahmad; Shahid Jameel
BackgroundSeveral subtypes of HIV-1 circulate in infected people worldwide, including subtype B in the United States and subtype C in Africa and India. To understand the biological properties of HIV-1 subtype C, including cellular tropism, virus entry, replication efficiency and cytopathic effects, we reciprocally inserted our previously characterized envelope V3–V5 regions derived from 9 subtype C infected patients from India into a subtype B molecular clone, pNL4-3. Equal amounts of the chimeric viruses were used to infect T-lymphocyte cell lines (A3.01 and MT-2), coreceptor cell lines (U373-MAGI-CCR5/CXCR4), primary blood T-lymphocytes (PBL) and monocyte-derived macrophages (MDM).ResultsWe found that subtype C envelope V3–V5 region chimeras failed to replicate in T-lymphocyte cell lines but replicated in PBL and MDM. In addition, these chimeras were able to infect U373MAGI-CD4+-CCR5+ but not U373MAGI-CD4+-CXCR4+ cell line, suggesting CCR5 coreceptor utilization and R5 phenotypes. These subtype C chimeras were unable to induce syncytia in MT-2 cells, indicative of non-syncytium inducing (NSI) phenotypes. More importantly, the subtype C envelope chimeras replicated at higher levels in PBL and MDM compared with subtype B chimeras and isolates. Furthermore, the higher levels subtype C chimeras replication in PBL and MDM correlated with increased virus entry in U373MAGI-CD4+-CCR5+.ConclusionTaken together, these results suggest that the envelope V3 to V5 regions of subtype C contributed to higher levels of HIV-1 replication compared with subtype B chimeras, which may contribute to higher viral loads and faster disease progression in subtype C infected individuals than other subtypes as well as rapid HIV-1 subtype C spread in India.
Bioorganic & Medicinal Chemistry | 2014
Bharat P. Bashyal; Brian P. Wellensiek; Rajesh Ramakrishnan; Stanley H. Faeth; Nafees Ahmad; A. A. Leslie Gunatilaka
Screening of a small library of natural product extracts derived from endophytic fungi of the Sonoran desert plants in a cell-based anti-HIV assay involving T-cells infected with the HIV-1 virus identified the EtOAc extract of a fermentation broth of Alternaria tenuissima QUE1Se inhabiting the stem tissue of Quercus emoryi as a promising candidate for further investigation. Bioactivity-guided fractionation of this extract led to the isolation and identification of two new metabolites, altertoxins V (1) and VI (2) together with the known compounds, altertoxins I (3), II (4), and III (5). The structures of 1 and 2 were determined by detailed spectroscopic analysis and those of 3-5 were established by comparison with reported data. When tested in our cell-based assay at concentrations insignificantly toxic to T-cells, altertoxins V (1), I (3), II (4), and III (5) completely inhibited replication of the HIV-1 virus at concentrations of 0.50, 2.20, 0.30, and 1.50 μM, respectively. Our findings suggest that the epoxyperylene structural scaffold in altertoxins may be manipulated to produce potent anti-HIV therapeutics.
The Open Virology Journal | 2013
Brian P. Wellensiek; Rajesh Ramakrishnan; Bharat P. Bashyal; Yvette Eason; A. A. Leslie Gunatilaka; Nafees Ahmad
Most antiretroviral drugs currently in use to treat an HIV-1 infection are chemically synthesized and lead to the development of viral resistance, as well as cause severe toxicities. However, a largely unexplored source for HIV-1 drug discovery is endophytic fungi that live in a symbiotic relationship with plants. These fungi produce biologically active secondary metabolites, which are natural products that are beneficial to the host. We prepared several hundred extracts from endophytic fungi of desert plants and evaluated the inhibitory effects on HIV-1 replication of those extracts that showed less than 30% cytotoxicity in T-lymphocytes. Those extracts that inhibited viral replication were fractionated in order to isolate the compounds responsible for activity. Multiple rounds of fractionation and antiviral evaluation lead to the identification of four compounds, which almost completely impede HIV-1 replication. These studies demonstrate that metabolites from endophytic fungi of desert plants can serve as a viable source for identifying potent inhibitors of HIV-1 replication.
Virology | 2009
Brian P. Wellensiek; Rajesh Ramakrishnan; Vasudha Sundaravaradan; Roshni Mehta; David T. Harris; Nafees Ahmad
We have recently shown an increased HIV-1 replication and gene expression in neonatal (cord) blood mononuclear cells compared with adult cells, which could be due to HIV-1 integration as it targets active host genes. Here we have characterized 468 HIV-1 integration sites within cord and adult blood T-lymphocytes and monocyte-derived macrophages (MDM) from five donors. Several functional classes of genes were identified by gene ontology to be over represented, including genes for cellular components, maintenance of intracellular environment, enzyme regulation, cellular metabolism, catalytic activity and cation transport. Numerous potential transcription factor binding sites at the sites of integration were identified. Furthermore, the genes at the site of integration, transcription factors which potentially bind upstream of the HIV-1 promoter and factors that assist HIV-1 integration were found to be expressed at higher levels in cord than adult cells. Taken together, these results suggest HIV-1 integration occurred in a more actively transcribed genes in neonatal cells compared with adult cells, which may help explain a higher level of HIV-1 gene expression and replication in neonatal compared with adult cells.
Proceedings of the National Academy of Sciences of the United States of America | 2006
Vasudha Sundaravaradan; Shailendra K. Saxena; Rajesh Ramakrishnan; Venkat R.K. Yedavalli; David T. Harris; Nafees Ahmad
Journal of Biomedical Science | 2003
Tobias Hahn; Rajesh Ramakrishnan; Nafees Ahmad
Retrovirology | 2006
Rajesh Ramakrishnan; Roshni Mehta; Vasudha Sundaravaradan; Tiffany Davis; Nafees Ahmad
AIDS Research and Human Retroviruses | 2005
Rajesh Ramakrishnan; Mohammad Hussain; Alison K. Holzer; Roshni Mehta; Vasudha Sundaravaradan; Nafees Ahmad
Retrovirology | 2006
Brian P. Wellensiek; Vasudha Sundaravaradan; Rajesh Ramakrishnan; Nafees Ahmad
AIDS Research and Human Retroviruses | 2015
Rajesh Ramakrishnan; Hongbing Liu; Andrew P. Rice